-

Virtual Incision Explores NVIDIA Isaac for Healthcare in Surgical Robotics

New AI-driven simulation platform has the potential to safely and efficiently design, test and deploy advanced robotic and autonomous systems for healthcare applications

LINCOLN, Neb.--(BUSINESS WIRE)--Virtual Incision Corporation, developer of the MIRA Surgical System, has announced plans to explore the use of NVIDIA Isaac for Healthcare in developing their next-generation surgical robotics platforms. Digital twin framework capabilities integrated with robotic learning tools will enable Virtual Incision’s developers to create highly realistic virtual environments to simulate surgical details and physiologic processes. Virtual Incision also continues to explore the NVIDIA Cosmos platform for the development of future surgical robots. The goal is to accelerate the product development cycle by leveraging comprehensive testing throughout digital prototyping, simulation and physical deployment.

“Developing a surgical robot is a rigorous process, and great care must be taken to ensure that the product is safe, smart and effective,” said John Murphy, chief executive officer of Virtual Incision. “As we work on future iterations of MIRA, we’re excited to use NVIDIA Isaac for Healthcare to bring our surgeons and patients the most advanced technologies safely and expeditiously.”

About the MIRA Surgical System

MIRA is the world’s first miniaturized robotic-assisted surgery (RAS) system. Its small, sleek form factor is designed to offer the benefits of RAS during colectomy procedures without the logistical inefficiencies of traditional mainframe robotics. The easily accessible device weighs approximately two pounds (less than one kg) and offers internal triangulation with shoulders, arms, and infinite wrist roll inside of the body. It can be used in any operating room – a dedicated mainframe room is unnecessary. With its drape- and dock-free design and portability, MIRA is quick to set up, clean up, and move between cases. Its conveniently accessible design positions it to be used as a standalone system or a complementary tool for facilities that already own a mainframe. With MIRA, every operating room is RAS-ready.

About Virtual Incision

Virtual Incision is on a mission to simplify robotic-assisted surgery (RAS), so more patients and their surgeons can access its benefits every day. Headquartered in Lincoln, Nebraska, and holding over two hundred patents and patent applications, the company developed MIRA, the first-of-its-kind miniature RAS system. Virtual Incision’s goal is to make every operating room RAS-ready. For more information, visit our website or follow us on LinkedIn and X.

Important Safety Information

The MIRA Surgical System is intended for prescription use only. Patients should talk to their doctor to decide if surgery with a MIRA Surgical System is right for them. For important safety information, indications for use, risks, and warnings, please refer to www.virtualincision.com/safety-information.

Cautionary Note Regarding Forward-Looking Statements

This communication contains statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include but are not limited to, statements regarding our plans, beliefs, expectations, assumptions, and other statements that are not necessarily historical facts. You are cautioned that these forward-looking statements are only predictions and involve risks and uncertainties. Further, any forward-looking statement speaks only as of the date on which it is made, and we do not intend to update or revise any forward-looking statements. This communication also contains market data related to our business and industry which includes projections that are based on several assumptions we believe are reasonable and most significant to the projections as of the date of this communication. If any of our assumptions prove to be incorrect, our actual results may significantly differ from our projections based on these assumptions.

Contacts

Media Contact
Ashlynn Meyer
Virtual Incision
ashlynn.meyer@virtualincision.com

Virtual Incision Corporation


Release Summary
Virtual Incision explores NVIDIA Isaac for Healthcare in surgical robotics
Release Versions

Contacts

Media Contact
Ashlynn Meyer
Virtual Incision
ashlynn.meyer@virtualincision.com

Social Media Profiles
More News From Virtual Incision Corporation

Virtual Incision Appoints Jim Alecxih as Chief Executive Officer

LINCOLN, Neb.--(BUSINESS WIRE)--Virtual Incision Corporation, the developer of the MIRA Surgical System authorized by the FDA through the De Novo regulatory pathway, today announced the appointment of Jim Alecxih as chief executive officer. Alecxih, a recognized commercial leader in the medical device industry, brings more than 30 years of experience advancing transformative surgical technologies worldwide, including a distinguished tenure at Intuitive Surgical, where he played a pivotal role i...

ADDING MULTIMEDIA U.S.-Based Remote Robotic-Assisted Surgery Demonstration Successfully Completed Through Collaborations with Virtual Incision, Sovato, City of Hope, and the University of Illinois Chicago

LINCOLN, Neb.--(BUSINESS WIRE)--Virtual Incision Corporation, the developer of the MIRA Surgical System (MIRA), the world’s first miniaturized robotic-assisted surgery (RAS) device, and Sovato Health, the world’s only comprehensive solution designed to enable remote surgery and procedure programs, today announced the successful completion of a preclinical demonstration of nearly 40,000 miles combined distance. Four surgeons performed a total of 20 procedures on porcine models as part of the rem...

Virtual Incision Announces Successful Completion of the First Hysterectomy Performed with the MIRA™ Surgical System

LINCOLN, Neb.--(BUSINESS WIRE)--Virtual Incision Corporation, the developer of the MIRA Surgical System (MIRA), today announced the successful completion of the first surgery in a clinical study assessing the safety and efficacy of its miniaturized robotic-assisted surgery (miniRAS) device in benign hysterectomy procedures. More than one million women in the U.S. alone undergo surgery for benign gynecologic conditions annually.1 A minimally invasive approach can shorten the hospital stay, reduc...
Back to Newsroom